Lataa...
Run-In Phase III Trial Design With Pharmacodynamics Predictive Biomarkers
BACKGROUND: Developments in biotechnology have stimulated the use of predictive biomarkers to identify patients who are likely to benefit from a targeted therapy. Several randomized phase III designs have been introduced for development of a targeted therapy using a diagnostic test. Most such design...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3888165/ https://ncbi.nlm.nih.gov/pubmed/24096624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt265 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|